Phacoemulsification with Goniosynechialysis versus Phacoemulsification Alone in Angle-Closure Glaucoma: A Meta-Analysis of Randomized Controlled Trials

Table 1

Summary of the characteristics of the included studies.

Author (year)	Study location	Study design	Type of glaucoma	No. of eyes		Mean age (years)		Sex (male/female)		Technique	Follow-up period
				Phaco-GSL	Phaco-alone	Phaco-GSL	Phaco-alone	Phaco-GSL	Phaco-alone		(months)
Varma/2010 [12]	UK	RCT	CACG	25	25	72.4 ± 8.9	72.96 ± 7.8	16/9	8/17	VGP	12
Moghimi/2015 [19]	Iran	RCT	PACG	45	46	61.6 ± 8.3	63.2 ± 6.9	19/26	19/27	VGP	12
Shao/2015 [20]	China	RCT	PACG	23	12	73.61 ± 8.44	69.85 ± 8.56	NR	NR	MGSL	6
Tun/2015 [13]	Singapore	RCT	PACG	11	11	66.75 ± 6.53	67.77 ± 5.18	3/8	2/9	MGSL	12
Xu/2017 [22]	China	RCT	PACG	46	50	53.62 ± 6.43	54.73 ± 6.58	28/18	30/20	MGSL	6
Rodrigues/2017 [21]	UK	RCT	PACG PAC	14	10	67.2 ± 8.4	66.1 ± 7.4	5/9	5/5	MGSL	6
Husain/2019 [16]	Singapore/Vietnam/Thailand/Hong Kong	RCT	PACG PAC	38	40	68.1 ± 9.2	67.3 ± 8.6	13/25	11/29	MGSL	12
Angmo/2019 [15]	India	RCT	PACG	34	30	56.50 ± 9.17	58.77 ± 8.14	NR	NR	MGSL	6

CACG: chronic angle-closure glaucoma; MGSL: mechanical goniosynechialysis; NR: not reported; Phaco-alone: phacoemulsification alone; PAC: primary angle-closure; PACG: primary angle-closure glaucoma; Phaco-GSL: phacoemulsification with goniosynechialysis; RCT: randomized controlled trial; UK: United Kingdom; VGP: viscogonioplasty.